Project Grant HT94252510800
Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $382K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
- The federal Project Grant award of $992,302 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), located in Boston, MA. This grant, awarded on September 15, 2025, supports advanced biomedical research aimed at "Targeting MHCII Ubiquitination to Induce Immune Regulation in Vascularized Composite Tissue Transplantation". MGH, a...
- The Department of Defense's Defense Health Agency awarded a $1,385,292 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), with a performance period from August 15, 2025 to August 14, 2028. The grant is funded under the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Through this award,...
- The federal Project Grant award of $999,806.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to study innate lymphoid cells as new targets to reduce vascularized composite tissue transplant rejection. The award, which runs from September 30, 2024 to September 29, 2027, will enable MGH to conduct innovative biomedical research,...
- This $1,644,309 Project Grant was awarded on February 1, 2025 by the Defense Health Agency, which administers the Military Medical Research and Development program (CFDA 12.420), to The General Hospital Corporation (doing business as Massachusetts General Hospital) in Boston, MA. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the research will focus on functional molecular networks...
- The Massachusetts General Hospital was awarded a $999,792 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into regulatory T-cell expansion and immune modulation in vascularized composite tissue transplants from September 15, 2021 through September 14, 2024. The Military Medical Research and Development program supports biomedical research that transforms military and public...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $577,094 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Redirecting Viral Immunity to Eradicate Low Tumor Mutation Burden Lung Cancers." The award period runs from Aug 31, 2023 to Aug 29, 2025. As a leading academic medical center and research institution, MGH utilizes its...
- The Department of the Army Medical Command, through the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $1,498,368 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), with a performance period from August 1, 2024 to July 31, 2027. The grant supports research to elucidate the molecular mechanisms of tumor-immune dynamics and evolution in response to radiation, in order to optimize treatment of high-...
- The General Hospital Corporation, doing business as Massachusetts General Hospital, was awarded a $302,801 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from September 1, 2022 to August 31, 2025 to advance a tissue oxygenation measurement device and evaluate galectin-3 as novel noninvasive prognostic biomarkers for monitoring vascularized composite...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), has been awarded a $1,000,236.00 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, effective April 1, 2024 through March 31, 2028, will fund research to "UNLOCK THE CTDNA MUTATIONAL PATTERNS FOR EARLY CANCER DETECTION AND NONINVASIVE BIOMARKERS." As a leading academic medical center and research...
- This federal Project Grant award, valued at $1,155,518.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct in vivo neuroepigenetics research in combat veterans with repeated blast exposure. The award, with a performance period from September 1, 2025 to August 31, 2028, will support advanced biomedical research to transform...